DNMT3A and acute myeloid leukemia: We extended the panel of patient samples and demonstrated that clone 8.6F10 reacted against all HLA-A*01:01 and DNMT3AR882H-positive AML samples, whereas it again failed to react against AML cells with wildtype DNMT3A (Figure 5B and Figure S6).